| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.69 | 0.009 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.01 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |